| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 01/09/2001 | US6172096 Administering 4-pyrazolylbenzenesulfonamide derivatives to treat autoimmune diseases |
| 01/09/2001 | US6172080 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 01/09/2001 | US6172074 Imidazopyridines and oxazolopyridines |
| 01/09/2001 | US6172068 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 01/09/2001 | US6172060 Therapy for sexual disorders |
| 01/09/2001 | US6171840 LacC from streptococcus pneumoniae |
| 01/09/2001 | US6171835 ribH |
| 01/09/2001 | US6171783 Detecting parainfluenza virus-3 and respiratory syncytial virus infection by using fusion protein of antigenic proteins from both viruses |
| 01/09/2001 | US6171598 GTP cyclohydrolase II (RIBA) |
| 01/04/2001 | WO2001000830A1 Sgip peptides |
| 01/04/2001 | WO2001000824A2 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 01/04/2001 | WO2001000812A2 22012, a novel human carboxypeptidase |
| 01/04/2001 | WO2001000811A2 17867, a novel human aminopeptidase |
| 01/04/2001 | WO2001000790A1 Production of the lipidated form of the peptidoglycan-associated lipoproteins of gram-negative bacteria |
| 01/04/2001 | WO2001000676A1 Somatostatin agonists |
| 01/04/2001 | WO2001000660A1 INHIBITORS OF THE INTEGRIN αvβ¿6? |
| 01/04/2001 | WO2001000655A2 Therapeutic peptides derived from subsequences of bpi |
| 01/04/2001 | WO2001000622A1 Prodrugs of carbamate inhibitors of impdh |
| 01/04/2001 | WO2001000615A1 Respiratory syncytial virus replication inhibitors |
| 01/04/2001 | WO2001000612A2 Respiratory syncytial virus replication inhibitors |
| 01/04/2001 | WO2001000610A1 Substituted benzimidazole |
| 01/04/2001 | WO2001000247A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 01/04/2001 | WO2001000244A2 METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATES |
| 01/04/2001 | WO2001000210A1 Reverse-turn mimetics and methods relating thereto |
| 01/04/2001 | WO2001000209A1 Methods of use of fluoroquinolone compounds against bacteria |
| 01/04/2001 | WO2001000206A1 Vla-4 inhibitor compounds |
| 01/04/2001 | WO2001000047A1 Prophylactic dietary supplement based on milk |
| 01/04/2001 | WO2001000015A1 Goodpasture's syndrome model mouse |
| 01/04/2001 | WO2000060082A3 Vesicle associated proteins |
| 01/04/2001 | WO2000059449A3 Purine derivatives having phosphodiesterase iv inhibition activity |
| 01/04/2001 | WO2000056358A3 Vaccine against streptococcus pneumoniae capsular polysaccharides |
| 01/04/2001 | WO2000051578A3 Use of ceramides for the treatment of cystic fibrosis |
| 01/04/2001 | WO2000044761A3 Ketolide antibiotics |
| 01/04/2001 | WO2000038715A3 Use of an integrin antagonist and radiation in the treatment of neoplasia |
| 01/04/2001 | WO2000031095A3 Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation |
| 01/04/2001 | CA2377721A1 Sgip peptides |
| 01/04/2001 | CA2377265A1 Somatostatin agonists |
| 01/04/2001 | CA2377224A1 Inhibitors of the integrin .alpha.v.beta.6 |
| 01/04/2001 | CA2376859A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 01/04/2001 | CA2376785A1 Benzimidazoles and imidazopyridines as respiratory syncytial virus replication inhibitors |
| 01/04/2001 | CA2375952A1 Reverse-turn mimetics and methods relating thereto |
| 01/04/2001 | CA2370887A1 Production of the lipidated form of the peptidoglycan-associated lipoproteins of gram-negative bacteria |
| 01/04/2001 | CA2369308A1 Vla-4 inhibitor compounds |
| 01/03/2001 | EP1064945A1 Therapeutic use of a helium/oxygen mixture, especially for treating asthma |
| 01/03/2001 | EP1064376A2 GFR$g(a)3 AND ITS USES |
| 01/03/2001 | EP1064308A1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 01/03/2001 | EP1064277A1 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines |
| 01/03/2001 | EP1064262A1 Substituted isoindolones and their use as cyclic gmp modulators in medicaments |
| 01/03/2001 | EP1064010A1 Peptide compositions and formulations and use of same |
| 01/03/2001 | EP1063996A1 Pharmaceutical compositions containing in combination two antagonists selective of arginine-vassopressin v receptors, even of v 1a? and v 2? receptors |
| 01/03/2001 | EP1063987A1 Dietary control of arachidonic acid metabolism |
| 01/03/2001 | EP1063982A2 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders |
| 01/03/2001 | EP1063968A1 Improved compositions for inhalation |
| 01/03/2001 | EP1063885A1 Xylitol compositions for treating upper respiratory conditions |
| 01/03/2001 | EP0815126B1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
| 01/03/2001 | EP0708776B1 Antiallergic imidazoazepines |
| 01/03/2001 | CN1278822A 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 01/03/2001 | CN1278821A Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 01/03/2001 | CN1278820A Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 01/03/2001 | CN1278805A Novel heterocyclioally substituted and a-hydroxycarboxlic acid derivatives, method for producing the same and their use as endothelin receptor antagonists |
| 01/03/2001 | CN1278802A Benzoxazine and Benzothiazine derivatives and their use in pharmaceuticals |
| 01/03/2001 | CN1278796A Method for the synthesis of quinoline derivatives |
| 01/03/2001 | CN1278790A Chemical compound |
| 01/03/2001 | CN1278789A 9,10-Dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors |
| 01/03/2001 | CN1278736A Hmanized antibodies to human gp39, compositions containing and therapeutic use thereof |
| 01/03/2001 | CN1278731A Use of mirtazapine for treating sleep apneas |
| 01/03/2001 | CN1278728A Compositions and methods for treating respiratory disorders |
| 01/03/2001 | CN1278726A IL-8 receptor antagonists |
| 01/03/2001 | CN1278722A 8a-azalides as veterinary antimicrobial agents for animals |
| 01/03/2001 | CN1278721A IL-8 receptor antagonists |
| 01/03/2001 | CN1278530A Novel peptide derivative |
| 01/03/2001 | CN1278443A Medicine for treating disease of upper respiratory tract and its preparation |
| 01/03/2001 | CN1278436A Chinese medicine for acute and chronic laryngopharyngitis |
| 01/03/2001 | CN1060171C Substituted biphenyl isoxazole sulfonamides |
| 01/03/2001 | CN1060081C Pure Chinese medicinal srup preparation and its production tech. |
| 01/02/2001 | US6169167 Antibodies to ligands for HEK4 receptors |
| 01/02/2001 | US6169090 Heterocyclic compounds and their therapeutic use |
| 01/02/2001 | US6169068 Treating lung disease or disorder by inhalating a protein |
| 01/02/2001 | US6168920 Extracellular adhesive proteins |
| 01/02/2001 | US6168790 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria |
| 01/02/2001 | US6168786 Chimeric protein containing a protein of parainfluenza virus (piv-3) and a protein of respiratory syncytial virus (rsv); capable of protecting infants and similar susceptible individuals against diseases caused by both piv and rsv |
| 01/02/2001 | US6167887 Selected C-10 perfluorinated hydrocarbons for liquid ventilation and artificial blood |
| 01/02/2001 | CA2054850C Cyclic imino derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 01/02/2001 | CA2025070C Recombinant aprotinin variants genetically engineered process for the microbial preparation of homgeneously processed aprotinin variants and the therapeutic use thereof |
| 01/01/2001 | WO2001003645A2 Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 12/28/2000 | WO2000078953A2 Human transport proteins |
| 12/28/2000 | WO2000078952A2 Human rna metabolism proteins (rmep) |
| 12/28/2000 | WO2000078812A1 Method and compounds for inhibiting activity of serine elastases |
| 12/28/2000 | WO2000078810A1 Surfactant protein c esters |
| 12/28/2000 | WO2000078768A1 Potassium channel openers |
| 12/28/2000 | WO2000078765A2 CHROMENO[4,3,2-de]ISOQUINOLINES AS POTENT DOPAMINE RECEPTOR LIGANDS |
| 12/28/2000 | WO2000078750A1 New pharmaceutically active compounds |
| 12/28/2000 | WO2000078746A1 Antiviral agents |
| 12/28/2000 | WO2000078735A1 Bicyclic heterocycles, medicaments containing these compounds, their use and methods for the production thereof |
| 12/28/2000 | WO2000078720A1 Novel dihydropyridine derivative |
| 12/28/2000 | WO2000078719A1 Dihydropyridine derivative |
| 12/28/2000 | WO2000078346A1 Novel anti-allergic agents |
| 12/28/2000 | WO2000078322A2 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 12/28/2000 | WO2000078319A1 Dihydropyrazine derivatives as npy antagonists |
| 12/28/2000 | WO2000055162A3 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |